Italy Drug Delivery Devices Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4387448
  • Report
  • Region: Italy
  • 74 pages
  • Mordor Intelligence
1 of 3
Italy’s drug delivery devices market is currently estimated to be worth USD 3.36 billion for the year 2014 and is expected to reach USD 9.35 billion by the end of 2020. The CAGR during this period of the forecast is 22.74%.

Currently, North America dominates the global market owing to the fact that there is greater awareness and increase per capita income. Europe is the second largest market in the world for drug delivery devices. This is due to the higher disposable income available and rapid innovations in new technologies that are being made available in the market. Germany is the current market leader in Europe.

This escalation is developing the need to analyze, review and forecast the growth of the drug delivery devices market. Owing to the rapid evolution of the market in the use of injectable drug delivery technology, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits.

Italy Drug Delivery Devices Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.

Drivers

Some of the factors driving the growth of the market are:

Increased prevalence of chronic diseases
Technological advances
Increase in individual therapy
Increased understanding about drug metabolism among the population
Requirement of controlled drug release
Restraints

Injuries and infections fear while usage, the high cost of development, and strict regulatory framework are the major challenges faced by the drug delivery market.

The report studies in detail the markets for different drug delivery devices, which include the injectable, transdermal, ocular, implantable, oral, nasal, topic and pulmonary drug delivery devices. Injectable drug delivery systems currently dominate the global market.

This Report Offers:

Market analysis for Italy’s drug delivery devices market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share for the next five years.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
The various applications of drug delivery devices have been discussed in detail, in addition to a comprehensive overview of the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Application of Drug delivery devices
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value-Chain Analysis
5.6 Product Life-Cycle Analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.9 Porter’s Five Forces
5.9.1 Bargaining Power of Suppliers
5.9.2 Bargaining Power of Consumers
5.9.3 Threat of New Entrants
5.9.4 Threat of Substitute Products and Services
5.9.5 Competitive Rivalry within the Industry
6. Market Drivers, Restraints, and Opportunities
6.1 Market Drivers
6.1.1 Increasing Prevalence of Chronic Diseases
6.1.2 Advancement in Drug Delivery Systems
6.1.3 Increasing Demand for Generic Drugs
6.1.4 Advancement in Self-Administration and Home Care Drug Delivery
6.2 Market Restraints
6.2.1 Stringent Regulatory Guidelines
6.2.2 Product Recalls
6.3 Opportunities
6.3.1 Unmet Medical Needs
7. Market Segmentation
7.1 Introduction
7.2 Oral Drug Delivery System
7.2.1 Solid Oral Drugs
7.2.1.1 Tablets
7.2.1.2 Capsules
7.2.1.3 Powders
7.2.1.4 Pills
7.2.2 Liquid Oral Drugs
7.2.2.1 Syrups
7.2.2.2 Solutions
7.2.3 Semi-Solid Oral Drugs
7.2.3.1 Gels
7.2.3.2 Emulsions
7.2.3.3 Suspensions
7.2.3.4 Elixers
7.3 Nasal Drug Delivery
7.3.1 Nasal Drops
7.3.2 Nasal Sprays
7.3.3 Nasal Powders
7.3.4 Nasal Gels
7.4 Pulmonary Drug Delivery
7.4.1 Metered Dose Inhalers
7.4.2 Dry Powder Inhalers
7.4.3 Nebulizers
7.5 Injectable Drug Delivery
7.5.1 General Injectables
7.5.2 Self -Injection Device
7.5.3 Needle Free injectors
7.5.4 Autoinjectors
7.5.5 Pen Injectors
7.5.6 Wearable Injectors
7.5.7 By Material
7.5.7.1 Glass
7.5.7.2 Plastic
7.5.8 By Product
7.5.8.1 Fillable Syringes
7.5.8.2 Prefilled Syringes
7.5.9 By Usability
7.5.9.1 Reusable Syringes
7.5.9.2 Disposable Syringe
7.6 Ocular Drug Delivery
7.6.1 Liquid Ocular Drug Delivery
7.6.2 Semi-solid Ocular Drug delivery
7.6.3 Ocular Devices
7.7 Topical Drug Delivery
7.7.1 Liquid Topical Drug Delivery
7.7.1.1 Suspensions
7.7.1.2 Solutions
7.7.2 Semi-Solid Topical Drug Delivery
7.7.2.1 Creams
7.7.2.2 Gels
7.7.2.3 Pastes
7.7.2.4 Ointments
7.7.2.5 Lotions
7.7.3 Solid Topical Drug Delivery
7.7.3.1 Suppositories
7.7.3.2 Powders
7.8 Transmucosal Drug Delivery
7.8.1 Buccal Drug Delivery
7.8.2 Sublingual Drug Delivery
7.8.3 Rectal Transmucosal Drug Delivery
7.8.4 Vaginal Transmucosal Drug Delivery
7.9 Implantable Drug Delivery
8. Market Segmentation by Geography
8.1 Introduction
8.2 Japan
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 Sanofi
10.2 Johnson and Johnson
10.3 Novartis AG
10.4 Pfizer
10.5 F. Hoffmann- La Roche Ltd.
10.6 3M Company
10.7 GlaxoSmithKline
10.8 Merck & Co. Inc.
10.9 Bayer AG
10.10 B Braun Melsungen AG
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll